CTO Europe 2023: Cancer clinical trials shift as sector goes digital
Opening the first day of the CTO Europe conference, experts set their sights on the impact of digital technologies on oncology trials.
External controls can augment low populations in rare disease trials
FDA rejects Aldeyra’s dry eye drug, asks for more clinical data
Rallybio outlines Phase II trial plans after positive Phase I data
FDA grants IDE to RTI Surgical for breast reconstruction device trial
Post-ventilation study wins Australian Clinical Trial of the Year Award
Analysis
View More
Themes
View MoreBerlin Cures announces expansion of long Covid drug study
The company aims to publish the first results from the trial next year.
More themes
Premium Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover premium insights powered by our properietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Junshi publishes positive Phase III results for Covid-19 pill VV116
University of Queensland’s vaccine shows virus-neutralising effect in trial
AIM ImmunoTech concludes dosing in Phase II post-Covid drug trial
COP27: Have we committed to our goals?